မာတိကာဆီ ကျော်သွား

သွေးနှင့် သွေးရောဂါ လေ့လာမှု ဘာသာရပ်

ကုသမှု ရလဒ်များ

Long-term follow-up for up to 5 years on the risk of leukaemic progression in thrombocytopenic patients with lower-risk myelodysplastic syndromes treated with romiplostim or placebo in a randomised double-blind trial. (window အသစ် ဖွင့်နေပါတယ်)

Kantarjian HM, Fenaux P, Sekeres MA, Szer J, Platzbecker U, Kuendgen A, Gaidano G, Wiktor-Jedrzejczak W, Carpenter N, Mehta B, Franklin J, Giagounidis A

ရင်းမြစ်‎: Lancet Haematol 2018;5(3):e117-e126.

Index လုပ်ထား‎: PubMed 29396092

DOI‎: 10.1016/S2352-3026(18)30016-4

https://www.ncbi.nlm.nih.gov/pubmed/29396092 (window အသစ် ဖွင့်နေပါတယ်)

Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients. (window အသစ် ဖွင့်နေပါတယ်)

Michallet M, Goldet K, Sobh M, Morisset S, Chelghoum Y, Thomas X, Barraco F, Ducastelle S, Labussière H, Renzullo C, Paillet C, Pivot C, Straaten PB, Denis A, Termoz A, Detrait M, Nicolini FE, Jaisson-Hot I.

ရင်းမြစ်‎: Cancer 2013;119(1):107-14.

Index လုပ်ထား‎: PubMed 22744794

DOI‎: 10.1002/cncr.27686

https://www.ncbi.nlm.nih.gov/pubmed/22744794 (window အသစ် ဖွင့်နေပါတယ်)